Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) shares were down 6.5% during mid-day trading on Wednesday . The company traded as low as $23.93 and last traded at $24.18. Approximately 90,930 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 242,660 shares. The stock had previously closed at […]
More Stories
Unemployment Claims Signal Labor Market Stabilization Ahead of Jobs Report
By Andrew Moran The number of Americans filing applications for state unemployment benefits was flat ahead of tomorrow’s highly anticipated...
More Than 20 States Sue Over Trump’s New Global Tariffs
By Matthew Vadum More than 20 states filed a lawsuit on March 5 in federal court against President Donald Trump’s...
At Least 9 Vessels Attacked in Gulf Since Iran War Began
By Owen Evans At least nine vessels have come under attack since the U.S.–Israel military operation against Iran began on...
Hegseth Signs Joint Declaration to Boost Counter-Cartel Efforts in Western Hemisphere
By Ryan Morgan DORAL, Florida.—U.S. Secretary of War Pete Hegseth joined military officials from across Latin America and the Caribbean...
Typical US Homeowners Stay 12 Years in Their Homes—20 Years in Los Angeles
By Mary Prenon U.S. homeowners stayed in their houses for about 12 years as of 2025—the longest median time since...
DOT Granting $100 Million to Improve Transportation in FIFA World Cup Host Cities
By Naveen Athrappully The federal government will invest $100.3 million to enhance public transportation in cities hosting the 2026 FIFA...